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Congenital hydrocephalus is a disorder presenting a degeneration of the periventricular 
cerebral parenchyma and the white matter, which causes significant mortality and life-long 
neurological complications. There are currently no effective therapies for congenital 
hydrocephalus. Bone marrow-derived mesenchymal stem cells (BM-MSC) are considered as 
a potential therapeutic tool in neurodegenerative diseases, due to their ability to migrate to 
degenerated tissues and the production of growth factors. In the present study, using an 
animal model of congenital hydrocephalus, the hyh mouse, it has been studied the capacity of 
the BM-MSC to reach the degenerated regions exhibiting glial reactions and their probable 
neuroprotector effects.     
The BM-MSC were isolated from two different sources: a) transgenic mice expressing the 
monomeric red fluorescent protein (mRFP1); b) wild type mice. In the second case, the BM-
MSC were labelled in vitro using bromodeoxyuridine, a fluorescent cell tracker and the 
lipophilic DiR. Before application, the cells were analysed using flow cytometry and 
immunofluorescence. The BM-MSC were injected into the retro-orbital sinus or into the 
lateral ventricle of hyh mice. After 24/96 hours of administration, the BM-MSC were 
detected under light, confocal and electron microscopes. 
The injected BM-MSC reached the degenerated periventricular regions and the disrupted 
neurogenic niches. They were detected in the periventricular parenchyma, around 
periventricular blood vessels and in the ventral meninges. Most of the applied BM-MSC 
expressed the glial cell-derived neurotrophic factor (GDNF), in the same way as the 
periventricular reactive astrocytes, suggesting a possible neuroprotector effect.  
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